勘误：一项由研究者发起的单臂研究，评估玻璃体内注射阿柏西普对曾接受雷珠单抗或贝伐单抗治疗的渗出性年龄相关性黄斑变性患者的疗效、安全性及耐受性（ASSESS研究）：12个月分析 [更正]
Erratum: A single-arm, investigator-initiated study of the efficacy, safety, and tolerability of intravitreal aflibercept injection in subjects with exudative age-related macular degeneration previously treated with ranibizumab or bevacizumab (ASSESS study): 12-month analysis [Corrigendum].
出版信息
Clin Ophthalmol. 2017 Feb 7;11:303. doi: 10.2147/OPTH.S116038. eCollection 2017.
Abstract
[This corrects the article on p. 1759 in vol. 9, PMID: 26445522.].
摘要
[这更正了第9卷第1759页上的文章， PMID: 26445522。]
Zotero 插件